ExodusPoint Capital Management, LP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 77 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$43,000
-12.2%
10,073
-13.1%
0.00%
-100.0%
Q1 2021$49,000
+4.3%
11,587
+5.9%
0.00%0.0%
Q2 2020$47,000
-72.8%
10,940
-44.2%
0.00%
-83.3%
Q3 2019$173,000
+51.8%
19,619
+59.3%
0.01%
+20.0%
Q2 2019$114,00012,3170.01%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2020
NameSharesValueWeighting ↓
TANG KEVIN 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 18,095$77,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders